EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access

A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature

Elise R Venable, Marie-France Gagnon, Beth A Pitel, Jeanne M Palmer, Jess F Peterson, Linda B Baughn, Nicole L Hoppman, Patricia T Greipp, Rhett P Ketterling, Mrinal S Patnaik, Katalin Kelemen, Xinjie Xu

Molecular Case Studies · 2023-02 · 9 (1) · a006243

DOI: 10.1101/mcs.a006243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Case Studies, online erschienen am 10.01.2023. Verfasst von Elise R Venable und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. Hauptthemen laut MEDLINE: Eosinophilia, Lymphoma, Myeloproliferative Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid/lymphoid neoplasms with FLT3 gene fusions have recently been included among myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) in the World Health Organization classification and International Consensus Classification. As this entity remains remarkably rare, its scope and phenotypic features are evolving. In this report, we describe a 33-yr-old male with MLN-TK. Conventional chromosome analysis revealed a t(13;14)(q12;q32). Further analysis with mate-pair sequencing (MPseq) confirmed a TRIP11::FLT3 gene fusion. A diagnosis of MLN-TK was rendered. To the best of our knowledge, we report the third case of MLN-TK with a TRIP11::FLT3 gene fusion. In contrast to previously described cases, our case exhibited distinctly mild clinical features and disease behavior, emphasizing the diverse spectrum of MLN-TK at primary presentation and variability in disease course. MLN-TK with FLT3 gene fusions are a genetically defined entity which may be targetable with tyrosine kinase inhibitors with anti-FLT3 activity. Accordingly, from diagnostic and therapeutic viewpoints, genetic testing for FLT3 rearrangements using fluorescence in situ hybridization (FISH) or sequencing-based assays should be pursued for patients with chronic eosinophilia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophiliaLymphomaMyeloproliferative DisordersHumansMaleCytoskeletal Proteinsfms-Like Tyrosine Kinase 3Gene FusionIn Situ Hybridization, FluorescenceOncogene Proteins, FusionProtein-Tyrosine KinasesAdult

Stichwörter der Autor:innen

eosinophiliahematological neoplasmmalignant eosinophil proliferation

Substanzen

Cytoskeletal ProteinsFLT3 protein, humanfms-Like Tyrosine Kinase 3Oncogene Proteins, FusionProtein-Tyrosine KinasesTRIP11 protein, human

Autor:innen und Institutionen

  • Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, Arizona 85054, USA.
  • Division of Hematopathology, Department of Laboratory Medicine and Pathology, Rochester, Minnesota 55905, USA.
  • Division of Hematology and Oncology, Department of Medicine Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Division of Hematopathology, Department of Laboratory Medicine and Pathology; Mayo Clinic, Phoenix, Arizona 85054, USA.

Zitieren

APA

Venable, E. R., Gagnon, M. F., Pitel, B. A., Palmer, J. M., Peterson, J. F., Baughn, L. B., Hoppman, N. L., Greipp, P. T., Ketterling, R. P., Patnaik, M. S., Kelemen, K., & Xu, X. (2023). A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature. Molecular Case Studies, 9(1), a006243. https://doi.org/10.1101/mcs.a006243

Vancouver

Venable ER, Gagnon MF, Pitel BA, Palmer JM, Peterson JF, Baughn LB, et al. A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature. Molecular Case Studies. 2023;9(1):a006243. doi:10.1101/mcs.a006243

BibTeX
@article{Venable2023,
  author = {Venable, Elise R and Gagnon, Marie-France and Pitel, Beth A and Palmer, Jeanne M and Peterson, Jess F and Baughn, Linda B and Hoppman, Nicole L and Greipp, Patricia T and Ketterling, Rhett P and Patnaik, Mrinal S and Kelemen, Katalin and Xu, Xinjie},
  title = {A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature},
  journal = {Molecular Case Studies},
  year = {2023},
  volume = {9},
  number = {1},
  pages = {a006243},
  doi = {10.1101/mcs.a006243}
}
Kostenlos starten →